查看購物車
  • Simplified Chinese
  • English
2021-2031年歐洲類器官市場報告：範圍、細分、動態與競爭分析
市場調查報告書
商品編碼
1871520

2021-2031年歐洲類器官市場報告：範圍、細分、動態與競爭分析

Europe Organoids Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 233 Pages | 訂單完成後即時交付

價格

歐洲類器官市場預計將大幅成長，到 2031 年將達到約 50.1603 億美元，高於 2023 年的 10.1812 億美元，在此期間的年複合成長率(CAGR) 為 22.1%。

執行摘要和市場分析

歐洲類器官市場分為多個區域，包括德國、法國、義大利、英國、西班牙和歐洲其他地區。該市場的成長受多種因素驅動，包括組織工程和器官移植需求的不斷成長、類器官在疾病建模、基因突變研究和腫瘤建模中應用的日益廣泛，以及與類器官相關的研究活動的增加。此外，來自公共和私營部門的資金和投資預計將在未來幾年為市場擴張創造良好的機會。

市場區隔分析

歐洲類器官市場可以透過多種細分市場進行分析，包括類型、應用、來源、供應和方法：

  • 類型：市場依類器官來源可分為腸道、肝臟、胃、胰臟、肺、腦、腎臟等。 2023年，腸道類器官佔據最大的市場佔有率。
  • 應用領域：類器官的應用包括發育生物學、傳染病病理學、再生醫學、藥物毒性和療效測試、藥物發現以及個人化醫療。 2023年，發育生物學應用佔據了市場主導地位。
  • 資料來源：市場分為源自多能幹細胞的類器官和源自器官特異性成體幹細胞的類器官，其中多能幹細胞在 2023 年將佔據更大的市場佔有率。
  • 產品/服務：此部分包括儀器、耗材和服務，其中耗材在 2023 年佔據市場主導地位。儀器又分為設備和儀器，而耗材包括感測器和其他物品。
  • 方法：類器官生產所使用的方法包括微圖案板、超低附著板、懸滴法、微滴法或乳液法，其中以懸滴法在 2023 年最為普遍。

市場展望

對創新藥物的需求正在加速藥物發現和研究的步伐。截至2021年，ClinicalTrials.gov網站上註冊的臨床試驗研究約有384,288項。 HUB的一項調查顯示，類器官可以透過識別不太可能從某些治療中獲益的患者來提高昂貴藥物的成本效益，從而最佳化臨床試驗設計。類器官不僅用於癌症研究，也用於囊性纖維化、多囊性腎病變、小頭畸形、腸道和呼吸道感染等相關疾病的研究。它們可以複製器官的特性，包括結構和功能，並能恢復組織的遺傳和表觀遺傳狀態，使其適用於基因編輯應用。

近期研究表明，將CRISPR-Cas9技術與類器官結合，有望在囊性纖維化等疾病的治療方面取得突破性進展。例如，2020年的一項研究重點介紹了一個包含664名囊性纖維化患者腸道類器官的生物樣本庫，其中相當一部分類器官可能受益於基因編輯。然而，基因編輯類器官的效率和成功率仍面臨挑戰，需要對其安全性、穩定性和功能性進行深入研究。目前，藥物研發正不斷聚焦於先前未探索的醫學領域，為類器官市場帶來了巨大的成長機會。

國家概況

歐洲類器官市場進一步按國家分析，德國在2023年佔據市場領導地位。德國以其強大的生物技術產業而聞名，該產業以高品質的產品和眾多大型生物技術公司為特徵。例如，位於明斯特的馬克斯·普朗克分子生物醫學研究所的研究人員在自動化生產中腦類器官方面取得了長足進步，增強了大規模研究和高通量藥物發現的潛力。

德國對組織工程和器官移植的需求預計將推動市場成長，因為器官供需之間存在巨大缺口。 2021年，德國僅捐贈了2,905個器官，而移植等待名單上的需求量卻高達8,730個。人類類器官正擴大被用於疾病研究，並有望成為可移植器官，從而緩解組織排斥反應和引入動物病原體的風險。

公司簡介

類器官市場的主要參與者包括STEMCELL Technologies Inc.、Molecular Devices、Hubrecht Organoid Technology、Definigen、Organoid Therapeutics、Thermo Fisher Scientific、Corning、Merck KGaA、InSphero、ACRO Biosystems、Bio-Techne、SUN bioscience、ORGANOID SCIS、Parto） Biologics、3Dnamics和Cellesce。這些公司正透過擴張、產品創新以及併購等多種策略來增強市場佔有率並提供創新解決方案。

目錄

第1章：引言

第2章：執行概要

  • 關鍵見解

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：

第4章：歐洲類器官市場－主要市場動態

  • 市場促進因素
    • 對腫瘤建模和生物樣本庫的需求日益成長
    • 個人化藥物的廣泛應用
  • 市場限制
    • 缺乏熟練的專業人才
  • 市場機遇
    • 重點關注藥物發現活動
  • 未來趨勢
    • 類器官與晶片器官的結合
  • 駕駛員和安全帶的影響：

第5章：類器官市場－歐洲分析

  • 2021-2031年歐洲類器官市場收入
  • 歐洲類器官市場預測分析

第6章：歐洲類器官市場分析－依類型

  • 腸
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第7章：歐洲類器官市場分析－按應用領域分類

  • 發育生物學疾病
  • 傳染病病理學
  • 再生醫學
  • 藥物毒性和療效測試
  • 藥物發現與個人化醫療
  • 其他

第8章：歐洲類器官市場分析－依來源分類

  • 多能幹細胞
  • 器官特異性成體幹細胞

第9章：歐洲類器官市場分析－依產品/服務分類

  • 儀器
  • 消耗品
  • 服務

第10章：歐洲類器官市場分析－依方法分類

  • 微圖案板
  • 超低附件板
  • 懸垂
  • 微滴或乳液
  • 其他

第11章：歐洲類器官市場—國家分析

  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第12章：行業概況

  • 概述
  • 類器官市場成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第13章：公司簡介

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems.
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd

第14章：附錄

Product Code: TIPRE00018856

The Europe organoids market is projected to grow significantly, reaching approximately US$ 5,016.03 million by 2031, up from US$ 1,018.12 million in 2023, reflecting a compound annual growth rate (CAGR) of 22.1% during this period.

Executive Summary and Market Analysis

The organoids market in Europe is divided into several regions, including Germany, France, Italy, the UK, Spain, and the Rest of Europe. The growth of this market is driven by several factors, including the increasing demand for tissue engineering and organ transplantation, the rising use of organoids in disease modeling, gene mutation studies, and tumor modeling, as well as heightened research activities related to organoids. Additionally, the influx of funding and investments from both public and private sectors is expected to create promising opportunities for market expansion in the coming years.

Market Segmentation Analysis

The Europe organoids market can be analyzed through various segments, including type, application, source, offering, and method:

  • Type: The market is categorized into organoids derived from the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, the intestine organoids held the largest market share.
  • Application: The applications of organoids include developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, and personalized medicine. Developmental biology applications dominated the market in 2023.
  • Source: The market is divided into organoids sourced from pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells holding a larger market share in 2023.
  • Offering: This segment includes instruments, consumables, and services, with consumables leading the market in 2023. Instruments are further divided into devices and equipment, while consumables include sensors and other items.
  • Method: The methods used in organoid production include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion techniques, with the hanging drop method being the most prevalent in 2023.

Market Outlook

The demand for innovative drugs is accelerating the pace of drug discovery and research. As of 2021, there were approximately 384,288 clinical trial studies registered on ClinicalTrials.gov. A survey by HUB indicates that organoids can enhance the cost-effectiveness of expensive drugs by identifying patients unlikely to benefit from certain treatments, thus optimizing clinical trial designs. Organoids are not only utilized in cancer research but also in studies related to cystic fibrosis, polycystic kidney disease, microcephaly, and infections affecting the gut and airways. They can replicate organ properties, including structure and function, and can restore the genetic and epigenetic states of tissues, making them suitable for gene editing applications.

Recent studies have shown promising results in combining CRISPR-Cas9 technology with organoids, leading to advancements in treatments for conditions like cystic fibrosis. For example, a 2020 study highlighted a biobank of cystic fibrosis intestinal organoids from 664 patients, with a significant portion potentially benefiting from gene editing. However, challenges remain regarding the efficiency and success rates of gene-edited organoids, necessitating further research into their safety, stability, and functionality. The ongoing focus on drug discovery in previously unexplored medical areas presents substantial growth opportunities for the organoids market.

Country Insights

The Europe organoids market is further analyzed by country, with Germany leading the market in 2023. Germany is recognized for its robust biotechnology sector, characterized by high-quality products and the presence of major biotechnology firms. For instance, researchers at the Max Planck Institute for Molecular Biomedicine in Munster have made strides in automating the production of midbrain organoids, enhancing the potential for large-scale research and high-throughput drug discovery.

The demand for tissue engineering and organ transplantation in Germany is expected to drive market growth, as there is a significant gap between organ supply and demand. In 2021, only 2,905 organs were donated, while the demand on the transplant list reached 8,730. Human organoids are increasingly being used to study diseases and have the potential to serve as transplantable organs, mitigating issues related to tissue rejection and the risk of introducing animal pathogens.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific, Corning, Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne, SUN bioscience, ORGANOID SCIENCES, Crown Bioscience, Sartorius AG, 3D Biotek, Prellis Biologics, 3Dnamics, and Cellesce. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Organoids Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 4.1.2 Surging Adoption of Personalized Drugs
  • 4.2 Market Restraints
    • 4.2.1 Dearth of Skilled Professionals
  • 4.3 Market Opportunities
    • 4.3.1 Focus on Drug Discovery Activities
  • 4.4 Future Trends
    • 4.4.1 Combination of Organoids and Organ-on-a-Chip
  • 4.5 Impact of Drivers and Restraints:

5. Organoids Market - Europe Analysis

  • 5.1 Europe Organoids Market Revenue (US$ Million), 2021-2031
  • 5.2 Europe Organoids Market Forecast Analysis

6. Europe Organoids Market Analysis - by Type

  • 6.1 Intestine
    • 6.1.1 Overview
    • 6.1.2 Intestine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Liver
    • 6.2.1 Overview
    • 6.2.2 Liver: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Stomach
    • 6.3.1 Overview
    • 6.3.2 Stomach: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Pancreas
    • 6.4.1 Overview
    • 6.4.2 Pancreas: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Lung
    • 6.5.1 Overview
    • 6.5.2 Lung: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Brain
    • 6.6.1 Overview
    • 6.6.2 Brain: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 Kidney
    • 6.7.1 Overview
    • 6.7.2 Kidney: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Europe Organoids Market Analysis - by Application

  • 7.1 Developmental Biology Disease
    • 7.1.1 Overview
    • 7.1.2 Developmental Biology Disease: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Pathology of Infectious Disease
    • 7.2.1 Overview
    • 7.2.2 Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Regenerative Medicine
    • 7.3.1 Overview
    • 7.3.2 Regenerative Medicine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Drug Toxicity and Efficacy Testing
    • 7.4.1 Overview
    • 7.4.2 Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Drug Discovery and Personalized Medicine
    • 7.5.1 Overview
    • 7.5.2 Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Organoids Market Analysis - by Source

  • 8.1 Pluripotent Stem Cells
    • 8.1.1 Overview
    • 8.1.2 Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Organ-Specific Adult Stem Cell
    • 8.2.1 Overview
    • 8.2.2 Organ-Specific Adult Stem Cell: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Organoids Market Analysis - by Offering

  • 9.1 Instruments
    • 9.1.1 Overview
    • 9.1.2 Instruments: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Consumables
    • 9.2.1 Overview
    • 9.2.2 Consumables: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Services
    • 9.3.1 Overview
    • 9.3.2 Services: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Organoids Market Analysis - by Method

  • 10.1 Micropatterned Plates
    • 10.1.1 Overview
    • 10.1.2 Micropatterned Plates: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.2 Ultralow Attachment Plates
    • 10.2.1 Overview
    • 10.2.2 Ultralow Attachment Plates: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.3 Hanging Drop
    • 10.3.1 Overview
    • 10.3.2 Hanging Drop: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.4 Microdroplet or Emulsion
    • 10.4.1 Overview
    • 10.4.2 Microdroplet or Emulsion: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. Europe Organoids Market - Country Analysis

  • 11.1 Europe
    • 11.1.1 Europe Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Europe Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 Germany: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.2.1 Germany: Europe Organoids Market Share - by Type
        • 11.1.1.2.2 Germany: Europe Organoids Market Share - by Application
        • 11.1.1.2.3 Germany: Europe Organoids Market Share - by Source
        • 11.1.1.2.4 Germany: Europe Organoids Market Share - by Offering
        • 11.1.1.2.5 Germany: Europe Organoids Market Share - by Instruments
        • 11.1.1.2.6 Germany: Europe Organoids Market Share - by Consumables
        • 11.1.1.2.7 Germany: Europe Organoids Market Share - by Method
      • 11.1.1.3 France: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.3.1 France: Europe Organoids Market Share - by Type
        • 11.1.1.3.2 France: Europe Organoids Market Share - by Application
        • 11.1.1.3.3 France: Europe Organoids Market Share - by Source
        • 11.1.1.3.4 France: Europe Organoids Market Share - by Offering
        • 11.1.1.3.5 France: Europe Organoids Market Share - by Instruments
        • 11.1.1.3.6 France: Europe Organoids Market Share - by Consumables
        • 11.1.1.3.7 France: Europe Organoids Market Share - by Method
      • 11.1.1.4 United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.4.1 United Kingdom: Europe Organoids Market Share - by Type
        • 11.1.1.4.2 United Kingdom: Europe Organoids Market Share - by Application
        • 11.1.1.4.3 United Kingdom: Europe Organoids Market Share - by Source
        • 11.1.1.4.4 United Kingdom: Europe Organoids Market Share - by Offering
        • 11.1.1.4.5 United Kingdom: Europe Organoids Market Share - by Instruments
        • 11.1.1.4.6 United Kingdom: Europe Organoids Market Share - by Consumables
        • 11.1.1.4.7 United Kingdom: Europe Organoids Market Share - by Method
      • 11.1.1.5 Italy: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.5.1 Italy: Europe Organoids Market Share - by Type
        • 11.1.1.5.2 Italy: Europe Organoids Market Share - by Application
        • 11.1.1.5.3 Italy: Europe Organoids Market Share - by Source
        • 11.1.1.5.4 Italy: Europe Organoids Market Share - by Offering
        • 11.1.1.5.5 Italy: Europe Organoids Market Share - by Instruments
        • 11.1.1.5.6 Italy: Europe Organoids Market Share - by Consumables
        • 11.1.1.5.7 Italy: Europe Organoids Market Share - by Method
      • 11.1.1.6 Spain: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.6.1 Spain: Europe Organoids Market Share - by Type
        • 11.1.1.6.2 Spain: Europe Organoids Market Share - by Application
        • 11.1.1.6.3 Spain: Europe Organoids Market Share - by Source
        • 11.1.1.6.4 Spain: Europe Organoids Market Share - by Offering
        • 11.1.1.6.5 Spain: Europe Organoids Market Share - by Instruments
        • 11.1.1.6.6 Spain: Europe Organoids Market Share - by Consumables
        • 11.1.1.6.7 Spain: Europe Organoids Market Share - by Method
      • 11.1.1.7 Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.7.1 Rest of Europe: Europe Organoids Market Share - by Type
        • 11.1.1.7.2 Rest of Europe: Europe Organoids Market Share - by Application
        • 11.1.1.7.3 Rest of Europe: Europe Organoids Market Share - by Source
        • 11.1.1.7.4 Rest of Europe: Europe Organoids Market Share - by Offering
        • 11.1.1.7.5 Rest of Europe: Europe Organoids Market Share - by Instruments
        • 11.1.1.7.6 Rest of Europe: Europe Organoids Market Share - by Consumables
        • 11.1.1.7.7 Rest of Europe: Europe Organoids Market Share - by Method

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Organoids Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 STEMCELL Technologies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Molecular Devices, LLC.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Hubrecht Organoid Technology
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Definigen
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Organoid Therapeutics
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Merck KGaA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ACRO Biosystems.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Techne Corp
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 SUN bioscience SA
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 ORGANOID SCIENCES Co., Ltd.
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Crown Bioscience Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Sartorius AG
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 3D Biotek LLC
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Prellis Biologics Inc.
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 3Dnamics Inc.
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Cellesce Ltd
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. Europe Organoids Market Segmentation
  • Table 2. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Offering
  • Table 7. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Method
  • Table 8. Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 9. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 10. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 11. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 12. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 13. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 14. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 15. Germany: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 16. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 20. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 21. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 22. France: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 23. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 24. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 25. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 26. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 27. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 28. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 29. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 30. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 31. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 32. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 33. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 34. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 35. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 36. Italy: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 37. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 38. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 39. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 40. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 41. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 42. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 43. Spain: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 44. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 45. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 46. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 47. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 48. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 49. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 50. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 51. Recent Organic Growth Strategies in Organoids Market
  • Table 52. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. Europe Organoids Market Segmentation - Country
  • Figure 2. Europe Organoids Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Liver: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Stomach: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Pancreas: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Lung: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Brain: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Kidney: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Europe Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Europe Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Organ-Specific Adult Stem Cell: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Europe Organoids Market Share (%) - by Offering (2023 and 2031)
  • Figure 25. Instruments: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Consumables: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Services: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Europe Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 29. Micropatterned Plates: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Ultralow Attachment Plates: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Hanging Drop: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Microdroplet or Emulsion: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Others: Europe Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Europe Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 35. Germany: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 36. France: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 37. United Kingdom: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 38. Italy: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 39. Spain: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 40. Rest of Europe: Europe Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 41. Growth Strategies in Organoids Market